VCM
BMY icon

Virtue Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Virtue Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-14,354
Closed -$929K – 367
2023
Q3 		$929K Hold
14,354
– – 0.16% 120
2023
Q2 		$929K Buy
14,354
+1,969
+16% +$132K 0.16% 120
2023
Q1 		$842K Sell
12,385
-10,982
-47% -$775K 0.14% 128
2022
Q4 		$1.68M Buy
23,367
+17,630
+307% +$1.33M 0.26% 59
2022
Q3 		$408K Sell
5,737
-1,830
-24% -$133K 0.06% 134
2022
Q2 		$583K Sell
7,567
-5,015
-40% -$382K 0.09% 100
2022
Q1 		$919K Buy
12,582
+477
+4% +$32K 0.14% 179
2021
Q4 		$755K Sell
12,105
-336
-3% -$19.7K 0.11% 212
2021
Q3 		$736K Buy
12,441
+3,439
+38% +$226K 0.13% 203
2021
Q2 		$601K Sell
9,002
-601
-6% -$39.2K 0.12% 208
2021
Q1 		$606K Sell
9,603
-293
-3% -$18.2K 0.14% 184
2020
Q4 		$614K Sell
9,896
-29,742
-75% -$1.83M 0.15% 180
2020
Q3 		$2.39M Sell
39,638
-1,212
-3% -$72.9K 0.59% 39
2020
Q2 		$2.4M Buy
+40,850
New +$2.44M 0.55% 48
2019
Q3 		– Sell
-15,684
Closed -$711K – 227
2019
Q2 		$711K Buy
+15,684
New +$731K 0.26% 108
2018
Q4 		– Sell
-16,378
Closed -$1.02M – 109
2018
Q3 		$1.02M Buy
16,378
+10,309
+170% +$612K 0.21% 117
2018
Q2 		$336K Buy
6,069
+2,688
+80% +$145K 0.16% 164
2018
Q1 		$172K Buy
3,381
+2,086
+161% +$134K 0.09% 199
2017
Q4 		$79K Buy
+1,295
New +$81K 0.04% 243

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Virtue Capital Management's BMY Position: Q4 2023 in Review

Virtue Capital Management sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 14,354 shares — an estimated $929K sold.

Virtue Capital Management first reported a position in BMY in Q4 2017 and held it in 19 quarters. The position peaked at $2.4M in Q2 2020. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

  • Virtue Capital Management reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
  • Virtue Capital Management sold 14,354 Bristol-Myers Squibb shares in Q4 2023, an estimated $929K.
  • Virtue Capital Management first reported a position in Bristol-Myers Squibb in Q4 2017 and held it in 19 quarters.
  • Virtue Capital Management's Bristol-Myers Squibb position peaked at $2.4M in Q2 2020.
  • 2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Virtue Capital Management's 13F filing for Q4 2023, filed 15 Feb 2024.